Karen N Keating
Overview
Explore the profile of Karen N Keating including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cleeland C, Keating K, Cuffel B, Elbi C, Siegel J, Gerlinger C, et al.
Sci Rep
. 2024 Jun;
14(1):14839.
PMID: 38937473
We developed a composite symptom score (CSS) representing disease-related symptom burden over time in patients with malignant pleural mesothelioma (MPM). Longitudinal data were collected from an open-label Phase IIB study...
2.
Albarmawi H, Nagarajan M, Onukwugha E, Gandhi A, Keating K, Appukkuttan S, et al.
Future Oncol
. 2020 Feb;
16(8):353-365.
PMID: 32043384
Characterize follicular lymphoma (FL) treatment patterns among elderly patients using a dataset with longer follow-up time. Using the linked Surveillance, Epidemiology and End Results-Medicare data, we identified patients diagnosed with...
3.
Albarmawi H, Onukwugha E, Keating K, Appukkuttan S, Yared J
J Geriatr Oncol
. 2019 Nov;
11(1):55-61.
PMID: 31706831
Objectives: To evaluate the overall survival benefit associated with follicular lymphoma (FL)-directed therapy among patients diagnosed with FL at 80+ years. Patients And Methods: This retrospective cohort study utilized the...
4.
Albarmawi H, Nagarajan M, Sun K, Gandhi A, Yared J, Keating K, et al.
Leuk Lymphoma
. 2019 Aug;
61(1):75-83.
PMID: 31389296
There is limited information on the cost burden associated with follicular lymphoma (FL) and how it compares to other non-Hodgkin lymphoma (NHL) subtypes. We examined the direct medical costs associated...
5.
Mendoza T, Williams L, Keating K, Siegel J, Elbi C, Nowak A, et al.
J Patient Rep Outcomes
. 2019 Jun;
3(1):34.
PMID: 31209661
Background: Symptom assessment requires psychometrically validated questionnaires that are easy to use, relevant to the disease, and quick to administer. The MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)...
6.
Williams L, Whisenant M, Mendoza T, Haq S, Keating K, Cuffel B, et al.
Qual Life Res
. 2018 Sep;
27(12):3229-3241.
PMID: 30187393
Purpose: Malignant pleural mesothelioma (MPM) is an aggressive cancer of the lung pleura. The MD Anderson Symptom Inventory (MDASI) is a patient-reported outcome (PRO) measure of symptom burden, the combined...
7.
Anderson R, Keating K, Doll H, Camacho F
Oncologist
. 2015 Jun;
20(7):831-8.
PMID: 26084809
Background: Skin toxicity (hand-foot syndrome/hand-foot skin reaction, HFS/R) related to antineoplastic therapy is a significant issue in oncology practice, with potentially large impacts on health-related quality of life (HRQL). Materials...
8.
Quadri N, Lloyd A, Keating K, Nafees B, Piccirillo J, Wild D
Otolaryngol Head Neck Surg
. 2013 Apr;
149(1):161-7.
PMID: 23554113
Objective: To validate the Sinonasal Outcome Test-16 and Activity Impairment Assessment in patients with acute bacterial sinusitis. Study Design: Data were used from a phase III clinical trial designed to...
9.
Keating K, Perfetto E, Subedi P
Expert Rev Pharmacoecon Outcomes Res
. 2009 Oct;
5(4):457-66.
PMID: 19807263
A better understanding of how antimicrobial therapies affect the total cost of lower uncomplicated urinary tract infection, including direct (e.g., doctor visits), indirect (e.g., productivity) and intangible (e.g., pain) costs...
10.
Tucker M, Brigio F, Sirotenko G, Keating K, Perfetto E, Wilson K, et al.
Postgrad Med
. 2009 Aug;
116(6 Suppl Treating):11-20.
PMID: 19667683
The current trial assessed differences in physician and patient symptom-severity perceptions in ambulatory outpatient females with uncomplicated urinary tract infections (uUTIs). We also investigated the efficacy and safety profile of...